CLINICAL_TRIALS ClinicalTrials.gov record update

A Pilot Trial Examining Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic Stem Cell Transplant Recipients Using Myeloablative Busulfan and Fludarabine

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02916979
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:31.433323+00:00
Published At: 2023-10-18T00:00:00+00:00
Record Updated At: 2023-10-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Leukemia, Lymphoid", "Leukemia, Myeloid", "Myelodysplastic Syndromes", "Myelofibrosis", "Lymphoma, Malignant", "Multiple Myeloma", "Waldenstrom Macroglobulinemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-10-18"
protocolSection.identificationModule.nctId: "NCT02916979"
protocolSection.identificationModule.officialTitle: "A Pilot Trial Examining Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators\u0027 Expression in Allogeneic Stem Cell Transplant Recipients Using Myeloablative Busulfan and Fludarabine"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.